Barclays
BNGO icon

Barclays’s Bionano Genomics BNGO Stock Holding History

Barclays’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$3 Sell
2
-1
-33% -$1 ﹤0.01% 5278
2026
Q2 		$3 Buy
+3
New +$4 ﹤0.01% 5315
2025
Q2 		– Sell
-3
Closed -$8 – 5273
2025
Q1 		$8 Hold
3
– – ﹤0.01% 5183
2024
Q4 		$58 Hold
3
– – ﹤0.01% 5194
2024
Q3 		$91 Hold
3
– – ﹤0.01% 5185
2024
Q2 		$136 Hold
3
– – ﹤0.01% 4745
2024
Q1 		$222 Hold
3
– – ﹤0.01% 4983
2023
Q4 		$378 Buy
+3
New +$313 ﹤0.01% 5140
2023
Q3 		– Sell
-3
Closed -$1.22K – 4605
2023
Q2 		$1.22K Sell
3
-253
-99% -$114K ﹤0.01% 4353
2023
Q1 		$171K Buy
256
+119
+87% +$106K ﹤0.01% 3886
2022
Q4 		$120K Buy
137
+113
+471% +$142K ﹤0.01% 4123
2022
Q3 		$27K Sell
24
-4
-14% -$5.28K ﹤0.01% 3967
2022
Q2 		$23K Sell
28
-57
-67% -$58.6K ﹤0.01% 4334
2022
Q1 		$130K Sell
85
-509
-86% -$687K ﹤0.01% 3667
2021
Q4 		$1.06M Buy
594
+398
+203% +$1.06M ﹤0.01% 2790
2021
Q3 		$645K Buy
196
+101
+106% +$353K ﹤0.01% 3045
2021
Q2 		$417K Buy
95
+91
+2,275% +$359K ﹤0.01% 3175
2021
Q1 		$17K Buy
+4
New +$22.6K ﹤0.01% 4393
2020
Q4 		– Sell
-1
Closed -$374 – 4891
2020
Q3 		$0 Sell
1
-199
-100% -$77.2K ﹤0.01% 5229
2020
Q2 		$61K Buy
+200
New +$50.2K ﹤0.01% 4834

Other funds holding BNGO

ACM
AIGH Capital Management Baltimore, Maryland $992M AUM 516.32% 1-Year Est. Return
Carret Asset Management
Carret Asset Management New York $1.14B AUM 25.06% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
WAM
Warberg Asset Management Winnetka, Illinois $755M AUM 21.42% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
TD Waterhouse Canada
TD Waterhouse Canada Toronto, Ontario, Canada $38.4B AUM 30.28% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return
Activest Wealth Management
Activest Wealth Management Aventure, Florida $540M AUM 34.92% 1-Year Est. Return

Barclays's BNGO Position: Q3 2026 in Review

Barclays reduced its Bionano Genomics (BNGO) stake by 33% in Q3 2026, selling an estimated $1 and leaving 2 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #5278.

Barclays first reported a position in BNGO in Q2 2020 and has held it in 20 quarters since. The position peaked at $1.06M in Q4 2021. 9 funds tracked by Wall St. Rank hold BNGO as of Q3 2026.

  • Barclays held 2 shares of Bionano Genomics worth $3 as of Q3 2026.
  • Barclays sold 1 Bionano Genomics share in Q3 2026, an estimated $1.
  • Bionano Genomics made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5278 holding.
  • Barclays first reported a position in Bionano Genomics in Q2 2020 and has held it in 20 quarters since.
  • Barclays's Bionano Genomics position peaked at $1.06M in Q4 2021.
  • 9 funds tracked by Wall St. Rank held Bionano Genomics as of Q3 2026.

Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.